```mermaid
flowchart TD
ANXIETY["ANXIETY<br/>Central Phenotype"]
STRESS["Stress<br/>Environmental Trigger"]
SEROTONIN["Serotonin<br/>Neurotransmitter"]
HIPPOCAMPUS["Ventral Hippocampus to<br/>mPFC Circuit"]
OXIDATIVE_STRESS["Oxidative Stress<br/>Pathway"]
NEURODEGENERATION["Neurodegeneration<br/>Process"]
DEPRESSION["Depression<br/>Comorbidity"]
ALZHEIMERS["Alzheimer's Disease<br/>Neurodegenerative Disease"]
MICROGLIA["Microglia<br/>Immune Cells"]
ASTROCYTES["Astrocytes<br/>Glial Cells"]
NEURONS["Neurons<br/>Primary Cells"]
ALS["ALS<br/>Motor Neuron Disease"]
ANXIETY_GENE["ANXIETY Gene<br/>Genetic Component"]
STRESS -->|"causes"| ANXIETY
SEROTONIN -->|"regulates"| ANXIETY
HIPPOCAMPUS -->|"regulates"| ANXIETY
ANXIETY -->|"associated_with"| DEPRESSION
ANXIETY -->|"associated_with"| ALZHEIMERS
ANXIETY -->|"activates"| NEURODEGENERATION
ANXIETY -->|"affects"| MICROGLIA
ANXIETY -->|"affects"| ASTROCYTES
ANXIETY -->|"affects"| NEURONS
ANXIETY -->|"activates"| OXIDATIVE_STRESS
NEURODEGENERATION -->|"activates"| ANXIETY
OXIDATIVE_STRESS -->|"activates"| ANXIETY
ASTROCYTES -->|"activates"| ANXIETY
ANXIETY_GENE -->|"activates"| ANXIETY
ANXIETY_GENE -->|"activates"| ALS
Anxiety disorders represent a group of psychiatric conditions characterized by excessive fear, worry, and autonomic hyperarousal that persist beyond appropriate triggers and impair daily functioning.[@role][@simulated] The major anxiety disorders include generalized anxiety disorder (GAD), panic disorder, social anxiety disorder (SAD), specific phobias, and separation anxiety disorder.[@role] These conditions affect approximately 12-30% of the population worldwide, making them among the most common psychiatric disorders.[@utility]
Beyond their primary psychiatric impact, anxiety disorders have significant associations with neurodegenerative diseases. Chronic anxiety may represent a prodromal marker or risk factor for conditions including [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease-disease) (PD), and vascular dementia.[@earlylife][@evolution] Understanding the neurobiological mechanisms underlying anxiety provides crucial insights into neurodegeneration and stress-related brain circuitry.
GAD is characterized by persistent, excessive worry about multiple domains (work, health, finances, relationships) for at least 6 months, accompanied by at least three of six somatic symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance.[@role]
Panic disorder involves recurrent, unexpected panic attacks (discrete periods of intense fear or discomfort) followed by persistent concern about additional attacks or behavioral changes to avoid them.[@role] Panic attacks include symptoms such as palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, and derealization.
SAD is characterized by marked fear or anxiety about one or more social situations where scrutiny is possible (public speaking, meeting unfamiliar people, eating in public).[@role] Social situations almost invariably provoke immediate anxiety, and patients recognize the fear as excessive.
Specific phobias involve marked fear or anxiety about a specific object or situation (animals, natural environment, blood-injury-injection, situational).[@role] The phobic stimulus almost always provokes immediate fear, and situations are avoided or endured with intense distress.
The amygdala serves as the central fear-processing hub, receiving sensory input via the thalamus and cortical pathways and coordinating responses through downstream hypothalamic and brainstem nuclei.[@simulated][^6] In anxiety disorders, amygdala hyperactivity is consistently observed on functional neuroimaging, correlating with symptom severity.[@simulated]
The extended amygdala, particularly the bed nucleus of the stria terminalis (BNST), mediates sustained anxiety responses and is implicated in generalized anxiety and anticipatory anxiety.[^6]
Anxiety disorders are associated with impaired prefrontal [cortex](/brain-regions/cortex) (PFC) regulation of amygdala responses.[^7] Reduced top-down inhibition from the ventromedial PFC (vmPFC) and dorsolateral PFC (dPFC) fails to suppress amygdala hyperactivity, resulting in exaggerated fear responses.[^7]
The hypothalamic-pituitary-adrenal (HPA) axis is dysregulated in chronic anxiety, with elevated baseline cortisol and impaired negative feedback.[^8] This chronic stress exposure may contribute to neurodegeneration through multiple mechanisms:
Multiple neurotransmitter systems are implicated in anxiety pathophysiology:[^9]
Anxiety symptoms are common in AD, with prevalence rates of 40-70% across disease stages.[@earlylife] Importantly, anxiety may precede cognitive decline in some patients, and several longitudinal studies suggest that anxiety in midlife increases AD risk.[@earlylife]
Proposed mechanisms linking anxiety to AD include:
Anxiety affects 30-50% of PD patients and may be a prodromal marker preceding motor symptoms.[@evolution] Anxiety in PD is associated with:
Anxiety symptoms are highly prevalent in vascular cognitive impairment and vascular dementia, potentially reflecting cerebrovascular disease affecting fear and anxiety circuits.[^11] White matter hyperintensities on MRI are associated with anxiety in elderly populations.[^11]
Anxiety disorders connect to numerous neurodegenerative disease pathways:
This section highlights recent publications relevant to this disease.